Improvements in 3D printing: Patent No. WO2017187114A1

Adam Perriman; James Armstrong; Madeline Burke; Benjamin Carter

Improvements in 3D printing: Patent No. WO2017187114A1

Adam Perriman
, James Armstrong
, Madeline Burke
, Benjamin Carter

Research output: Other contribution

Abstract

International Application published under the Patent Cooperation Treaty (PCT)
World Intellectual Property Organization: International Bureau (WIPO)

International Publication Number: WO/2017/187114
International Application Number: PCT/GB2016/053358

(EN) A novel hybrid biocompatible ink for templated 3D cell printing (bioprinting) is disclosed, which comprises a poloxamer in the range of from 11 to 14 wt %, and an alginate in the range of from 5 to 7 wt %. Methods for preparing the biocompatible ink and using the biocompatible ink to form an alginate gel structure are also disclosed.
(FR) L'invention concerne une nouvelle encre biocompatible hybride pour l'impression 3D de cellules dans une matrice (bio-impression), l'encre comprenant un poloxamère selon une proportion comprise entre 11 et 14 % en poids, et un alginate selon une proportion comprise entre 5 et 7 % en poids. L'invention concerne également des procédés de préparation de l'encre biocompatible et d'utilisation de l'encre biocompatible pour former une structure de gel d'alginate.

Original language	English
Media of output	Patent
Publisher	World Intellectual Property Organization (WIPO)
Number of pages	66
Publication status	Published - 2017
Externally published	Yes

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017187114&_cid=P22-MN6TDQ-62336-1

Cite this

@misc{50360e9e70e6445eba6fa47bf9d7e54f,

title = "Improvements in 3D printing: Patent No. WO2017187114A1",

abstract = "International Application published under the Patent Cooperation Treaty (PCT) World Intellectual Property Organization: International Bureau (WIPO) International Publication Number: WO/2017/187114 International Application Number: PCT/GB2016/053358 (EN) A novel hybrid biocompatible ink for templated 3D cell printing (bioprinting) is disclosed, which comprises a poloxamer in the range of from 11 to 14 wt \%, and an alginate in the range of from 5 to 7 wt \%. Methods for preparing the biocompatible ink and using the biocompatible ink to form an alginate gel structure are also disclosed. (FR) L'invention concerne une nouvelle encre biocompatible hybride pour l'impression 3D de cellules dans une matrice (bio-impression), l'encre comprenant un poloxam{\`e}re selon une proportion comprise entre 11 et 14 \% en poids, et un alginate selon une proportion comprise entre 5 et 7 \% en poids. L'invention concerne {\'e}galement des proc{\'e}d{\'e}s de pr{\'e}paration de l'encre biocompatible et d'utilisation de l'encre biocompatible pour former une structure de gel d'alginate.",

author = "Adam Perriman and James Armstrong and Madeline Burke and Benjamin Carter",

year = "2017",

language = "English",

publisher = "World Intellectual Property Organization (WIPO)",

type = "Other",

}

TY - GEN

T1 - Improvements in 3D printing

T2 - Patent No. WO2017187114A1

AU - Perriman, Adam

AU - Armstrong, James

AU - Burke, Madeline

AU - Carter, Benjamin

PY - 2017

Y1 - 2017

N2 - International Application published under the Patent Cooperation Treaty (PCT) World Intellectual Property Organization: International Bureau (WIPO) International Publication Number: WO/2017/187114 International Application Number: PCT/GB2016/053358 (EN) A novel hybrid biocompatible ink for templated 3D cell printing (bioprinting) is disclosed, which comprises a poloxamer in the range of from 11 to 14 wt %, and an alginate in the range of from 5 to 7 wt %. Methods for preparing the biocompatible ink and using the biocompatible ink to form an alginate gel structure are also disclosed. (FR) L'invention concerne une nouvelle encre biocompatible hybride pour l'impression 3D de cellules dans une matrice (bio-impression), l'encre comprenant un poloxamère selon une proportion comprise entre 11 et 14 % en poids, et un alginate selon une proportion comprise entre 5 et 7 % en poids. L'invention concerne également des procédés de préparation de l'encre biocompatible et d'utilisation de l'encre biocompatible pour former une structure de gel d'alginate.

AB - International Application published under the Patent Cooperation Treaty (PCT) World Intellectual Property Organization: International Bureau (WIPO) International Publication Number: WO/2017/187114 International Application Number: PCT/GB2016/053358 (EN) A novel hybrid biocompatible ink for templated 3D cell printing (bioprinting) is disclosed, which comprises a poloxamer in the range of from 11 to 14 wt %, and an alginate in the range of from 5 to 7 wt %. Methods for preparing the biocompatible ink and using the biocompatible ink to form an alginate gel structure are also disclosed. (FR) L'invention concerne une nouvelle encre biocompatible hybride pour l'impression 3D de cellules dans une matrice (bio-impression), l'encre comprenant un poloxamère selon une proportion comprise entre 11 et 14 % en poids, et un alginate selon une proportion comprise entre 5 et 7 % en poids. L'invention concerne également des procédés de préparation de l'encre biocompatible et d'utilisation de l'encre biocompatible pour former une structure de gel d'alginate.

M3 - Other contribution

PB - World Intellectual Property Organization (WIPO)

ER -

Improvements in 3D printing: Patent No. WO2017187114A1

Abstract

Access to Document

Fingerprint

Cite this